| Bioactivity | DBCO-PEG4-GGFG-Exatecan (DBCO-PEG4-GGFG-DX8951) is a drug-linker conjugate for ADC with potent antitumor activity by using DX8951 (a DNA topoisomerase I inhibitor), linked via the cleavable ADC linker DBCO-PEG4-GGFG[1]. |
| Invitro | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linke[1]. |
| Name | DBCO-PEG4-GGFG-Exatecan |
| CAS | 2694856-51-2 |
| Formula | C72H79FN10O17 |
| Molar Mass | 1375.45 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
DBCO-PEG4-GGFG-Exatecan
CAS: 2694856-51-2 F: C72H79FN10O17 W: 1375.45
DBCO-PEG4-GGFG-Exatecan (DBCO-PEG4-GGFG-DX8951) is a drug-linker conjugate for ADC with potent antitumor activity by usi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.